ABOUT K
ACADEMICS
ADMISSION
ALUMNI RELATIONS
GIVING TO K
NEWS & EVENTS
STUDENT LIFE
HORNET HIVE
ATHLETICS
SITEMAP
WEBMAIL
    • Login
    View Item 
    •   DSpace Home
    • Academic Departments, Programs, and SIPs
    • Biology
    • Diebold Symposium Posters and Schedules
    • View Item
    •   DSpace Home
    • Academic Departments, Programs, and SIPs
    • Biology
    • Diebold Symposium Posters and Schedules
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Permissibility of Various Colorectal Cancer Cell Lines to Tanapox Virus

    Thumbnail
    View/Open
    (1.011Mb)
    Date
    2013
    Author
    Tareen, Kinza
    Metadata
    Show full item record
    Abstract
    Oncolytic virotherapy represents an emerging treatment option that employs replication-competent viruses in targeting and destroying cancer cells. In fact, many viruses exhibit preferential, but nonexclusive, tropisms for tumor cells. This viral advantage evolved in tumor cells as a result of the tumor’s evolution to resist both detection and destruction by the immune system. Furthermore, tumor cells are resistant to apoptosis and translational suppression, two defense mechanisms employed by normal cells to combat viral infection. Tanapox virus (TPV) is considered a candidate for oncolytic viral therapy because TPV is capable of replicating in human cell lines, and under normal conditions TPV only produces mild infections, resulting in a relatively safe virus to work with. Furthermore, the life cycle of TPV also presents an advantageous trait for oncolytic virotherapy. TPV’s replication cycle is similar to that of its poxvirus family members, however the replication cycle observed in vitro is longer when compared to that of vaccinia virus (a poxvirus that has show oncolytic promise). This study aimed to determine the susceptibility and extent of productivity of TPV Kenya (TPV) modified with the insertion of enhanced green fluorescence protein (TPV-GFP), in three distinct colorectal cell lines (HCT-116, COLO-205, WI-38), and compare the findings to OMK cells, a known TPV-GFP host and WiDr, a non-cancerous cell line.
    URI
    http://hdl.handle.net/10920/28668
    Collections
    • Diebold Symposium Posters and Schedules [291]

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

    My Account

    Login

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
     

     

    K logo
    Kalamazoo College
    1200 Academy Street
    Kalamazoo Michigan 49006-3295
    USA
    Info 269-337-7000
    Admission 1-800-253-3602
    ABOUT K
    ACADEMICS
    ADMISSION
    ALUMNI RELATIONS
    GIVING TO K
    NEWS & EVENTS
    STUDENT LIFE

    Sitemap
    Map and Directions
    Contacts
    Directories
    Nondiscrimination Policy
    Consumer Information
    Official Disclaimer
    Search this site





    Academic Calendars
    Apply
    Bookstore
    Crisis Response
    Employment
    Library
    Registrar